(Q33383459)

English

Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma

scientific article

Statements

Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma (English)
Thomas M Habermann
Glen Justice
Kyle McBride
Kenton Wride
Annette Ervin-Haynes
Kenichi Takeshita
Dennis Pietronigro
Jerome B Zeldis
Joseph M Tuscano
24 February 2009

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit